TuHURA Biosciences, Inc. Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

TAMPA, Fla., July 1, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that the Company has been added to the Russell 3000^® Index, with automatic inclusion in the Russell 2000^® Index, as a part of the 2025 Russell indexes annual reconstitution. The Company's addition to the Russell 3000^® Index and the Russell 2000^® Index was effective as of market close, Friday, June 27^th, 2025.

Read more at prnewswire.com